GGrantIndex
← Leaderboards

Christopher Locher

Versatope Therapeutics, Inc.

$7,538,249
Attributed
$7,538,249
Total exposure
6
Grants
6
Lead (contact PI)

Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).

Funding over time

peak $4.6M · FY201825
$5M$3.8M$2.5M$1.3M$0
'18
'19
'20
'21
'22
'23
'24
'25

Funding mix

By agency

NIH$7,313,249 · 5
CDC$225,000 · 1

By mechanism

N01$4,563,592 · 1
R44$1,999,755 · 1
R43$974,902 · 4

Top collaborators

No co-investigators on record.

Others in their field

Other Emerging Leaders on “Animal Model

Research focus

Animal ModelResponseVaccinesToxicologyVaccine CandidateSafetyImmunogenicityLipopolysaccharidesMembraneVesicleInnovationAntibodiesImmunityManufactureImmune ResponseToxic EffectAntigensRecombinantsProbioticsScale UpEscherichia ColiProgramsAdjuvantAntibody-Mediated Protection

Grant awards (8)